| Financial Year |
March 31 2023 |
| Monetary Funds |
2,364,727,113.97 |
| Held-for-trading Financial Assets |
1,589,402,224.18 |
| Notes Receivable |
73,750.00 |
| Accounts Receivable |
54,567,496.25 |
| Advances to Suppliers |
5,694,874.89 |
| Other Receivables |
7,944,570.23 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
124,735,090.40 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,496,987.01 |
| Total Current Assets |
4,155,642,106.93 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
14,721,979.83 |
| Investment Properties |
-- |
| Fixed Assetes |
267,182,501.32 |
| Under-construction Projects |
19,399,795.67 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
113,208,398.22 |
| R&D expenses |
-- |
| Goodwill |
17,662,564.38 |
| Long-Term Deferred and Prepaid Expenses |
2,343,127.74 |
| Deferred Income Tax Assets |
24,426,744.01 |
| Other Non-Current Assets |
8,820,666.95 |
| Sub-Total of Non-Current Assets |
482,705,365.43 |
| Total Assets |
4,638,347,472.36 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
38,068,091.83 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,939,451.54 |
| Taxes Payable |
33,066,705.06 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
33,098,444.98 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,486,831.25 |
| Other Current Liabilities |
1,591,906.91 |
| Sub-Total of Current Liabilities |
171,117,659.68 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
93,342.56 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,128,063.61 |
| Total Liabilities |
174,245,723.29 |
| Paid-In Capital(Or Share Stock) |
145,974,775.00 |
| Capital Surplus |
2,819,165,917.63 |
| Surplus Reserve |
72,987,387.50 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,391,516,215.37 |
| Minority Stockholder's Interest |
34,457,453.57 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,429,644,295.50 |
| Owner's Equity（Stockholder's Equity） |
4,464,101,749.07 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,638,347,472.36 |
